We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Loss of Neuronal Enzyme Underlies Rare Childhood Epileptic Encephalopathy

By Gerald M. Slutzky, PhD
Posted on 08 Dec 2016
Print article
Image: A neuron in culture was transduced with a virus that expresses a green fluorescent protein and an inhibitory RNA that causes loss of the DENND5A protein. The neurons where then stained with a marker of neuronal processes in red (Photo courtesy of Peter McPherson Laboratory, Montreal Neurological Institute, McGill University).
Image: A neuron in culture was transduced with a virus that expresses a green fluorescent protein and an inhibitory RNA that causes loss of the DENND5A protein. The neurons where then stained with a marker of neuronal processes in red (Photo courtesy of Peter McPherson Laboratory, Montreal Neurological Institute, McGill University).
A recessive mutation causing loss of an enzyme required for neuronal development was shown to underlie a rare form of childhood epileptic encephalopathy.

Epileptic encephalopathy, which is often linked to improper development of the brain, is a rare but devastating sub-form of epilepsy that results in severe mental and physical disabilities in children from birth. To better understand the genetic and mechanistic causes of this disease, investigators at McGill University (Montreal, Canada) and collaborators in Canada, Saudi Arabia, Jordan, and Germany performed whole exome sequencing on three children with epileptic encephalopathy from two families, one from Saudi Arabia and another from Jordan.

The investigators reported in the November 17, 2016, online edition of the American Journal of Human Genetics that epileptic encephalopathy, which featured cerebral calcifications and coarse facial features, was caused by recessive loss-of-function mutations in the gene DENND5A.

DENND5A contains a DENN domain, an evolutionarily ancient enzymatic module conferring guanine nucleotide exchange factor (GEF) activity to multiple proteins serving as GEFs for Rab proteins, which are key regulators of membrane trafficking. DENND5A is detected predominantly in neuronal tissues, and its highest levels occur during development. Knockdown of DENND5A leads to striking alterations in neuronal development.

Mechanistically, changes caused by lack of DENND5A activity appeared to result from upregulation of neurotrophin receptors, leading to enhanced downstream signaling. Neurotrophins are a family of proteins involved in the survival, development, and function of neurons.

"Our study demonstrates the importance of membrane trafficking in neuronal development and it provides a new pathophysiological mechanism for this disease type. This will allow physicians around the world to test if mutations in DENND5A are causing the disease in their patients, and also to provide genetic counseling for affected families," said first author Dr. Chanshuai Han, a neurodegenerative disease researcher at McGill Univesity.

Related Links:
McGill University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.